Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: Impact on chronic inflammation

PLoS ONE

Volumn 4, Issue 2, 2009, Pages

  Hörmannsperger, Gabriele ^a   Clavel, Thomas ^a   Hoffmann, Micha ^a   Reiff, Caroline ^b   Kelly, Denise ^b   Loh, Gunnar ^c   Blaut, Michael ^c   Hölzlwimmer, Gabriele ^d   Laschinger, Melanie ^a   Haller, Dirk ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 6; LACTOBACILLUS CASEI EXTRACT; MESSENGER RNA; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR; VSL3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHRONIC INFLAMMATION; COLITIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; HUMAN; HUMAN CELL; ILEITIS; LACTOBACILLUS CASEI; LYMPHOCYTE MIGRATION; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; T LYMPHOCYTE ACTIVATION; UBIQUITINATION;

BACTERIA (MICROORGANISMS); LACTOBACILLUS CASEI; MUS;

EID: 84856825811     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004365     Document Type: Article

References (52)

1. Loftus E (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gasteroenterology 126: 1504-1517.
2. Cho JH (2008) The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8: 458-466.
3. Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134: 577-594.
4. Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, et al. (2003) Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124: 1202-1209.
5. Gionchetti P, Rizzello F, Morselli C, Poggioli G, Tambasco R, et al. (2007) High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum 50: 2075-2082; discussion 2082-2074.
6. Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, et al. (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53: 1617-1623.
7. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354: 635-639.
8. Isaacs K, Herfarth H (2008) Role of probiotic therapy in IBD. Inflamm Bowel Dis 14: 1597-1605.
9. Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, Sartor RB (2005) VSL#3 probiotic mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol. 100: 1539-1546.
10. Pronio A, Montesani C, Butteroni C, Vecchione S, Mumolo G, et al. (2008) Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. Inflamm Bowel Dis 14: 662-668.
11. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, et al. (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119: 305-309.
12. Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, et al. (2004) Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53: 108-114.
13. Soo I, Madsen KL, Tejpar Q, Sydora BC, Sherbaniuk R, et al. (2008) VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation. Can J Gastroenterol 22: 237-242.
14. Tursi A, Brandimarte G, Giorgetti GM, Forti G, Modeo ME, et al. (2004) Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med Sci Monit 10: PI126-131.
15. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, et al. (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121: 580-591.
16. Petrof KK, Ropeleski MJ, et al. (2004) Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 127: 1474-1487.
17. Giacinto C, Marinaro M, Massimo S, Strober W, Boirivant M (2005) Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells. Journal of Immunology 174: 3237-3246.
18. Artis D (2008) Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 8: 411-420.
19. Clavel T, Haller D (2007) Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation. Inflamm Bowel Dis 13: 1153-1164.
20. Banks C, Bateman A, Payne R, Johnson P, Sheron N (2003) Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 199: 28-35.
21. Hyun J, Lee G, Brown JB, Grimm GR, Tang Y, Mittal N, Dirisina R, Zhang Z, FryerJP, Weinstock JV, Luster AD, Barrett TA (2005) Anti-interferon-inducible chemokine, CXCL10, reduces colitis by impairing T helper-1 induction and recruitment in mice. Inflamm Bowel Dis 11: 799-805.
22. Suzuki K, Kawauchi Y, Palaniyandi SS, Veeraveedu PT, Fujii M, Yamagiwa S, Yoneyama H, Han GD, Kawachi H, Okada Y, Ajioka Y, Watanabe K, Hosono M, Asakura H, Aoyagi Y, Narumi S (2007) Blockade of interferon-gamma-inducible protein-10 attenuates chronic experimental colitis by blocking cellular trafficking and protecting intestinal epithelial cells. Pathol Int 57: 413-420.
23. Kamada N, Maeda K, Inoue N, Hisamatsu T, Hibi T (2008) Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells. Infect. Immun. 76: 214-220.
24. Otte JM, Podolsky DK (2004) Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 286: G613-G626.
25. Vidal K, Grosjean I, evillard JP, Gespach C, Kaiserlian D (1993) Immortalization of mouse intestinal epithelial cells by the SV40-large T gene. Phenotypic and immune characterization of the MODE-K cell line. J Immunol Methods 166: 63-73.
26. Graham FL, Smiley J, Russell WC, Nairn R (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74.
27. Ruiz P, Shkoda A, Kim SC, Sartor RB, Haller D (2005) IL-10 gene deficient mice lack TGFβ/Smad signalling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonisation with colitogenic Enterococcus faecalis. J Immunol 174: 2990-2999.
28. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
29. Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, Raz E (2005) Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 115: 695-702.
30. Tilsala-Timisjärvi A, Alatossava T (1997) Development of oligonucleotide primers from the 16S-23s rRNA intergenic sequences for identifying different dairy and probiotic lactic acid bacteria by PCR. International Journal of Food Microbiology 35: 49-56.
31. Ohmori Y, Hamilton TA (1993) Cooperative interaction between interferon (IFN) stimulus response element and kappaB sequence motifs controls IFNy- and lipopolysaccharid-stimulated transcription from the murine IP10 promoter. Journal of Biological Chemistry 268(9): 6677-6688.
32. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G (1999) Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10: 387-398.
33. Strober W, Fuss IJ, Blumberg RS (2002) The immunology of mucosal models of inflammation. Annu Rev Immunol 20: 495-549.
34. Yan F, Cao H, Cover TL, Whitehead R, Polk DB (2007) Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterol. 132: 562-575.
35. Marx N, MAch F, Sauty A, Leung JH, Sarafi MN, Ransohoff RM, Libby P, Plutzky J, Luster AD (2000) Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J Immunol 164: 6503-6508.
36. Inatomi O, Andoh A, Kitamura K, Yasui H, Zhang Z, Fujiyama Y (2005) Butyrate blocks interferon-gamma-inducible protein-10 release in human intestinal subepithelial myofibroblasts. J Gastroenterol. 40: 483-489.
37. Tebo J, Kim HS, Gao J, Armstrong DA, Hamilton TA (1998) Interleukin-1 suppresses IP-10 gene transcription by inhibiting the production of class I interferon. Blood 92: 4742-4749.
38. Proost P, Struyf S, Van Damme J (2006) Natural post-translational modifications of chemokines. Biochem Soc Trans. 34: 997-1001.
39. Yu Y, ZEng H, Lyons S, Carlson A, Merlin D, Neish AS, Gewirtz AT (2003) TLR5-mediated activation of p38 MAPK regulates epithelial IL-8 expression via posttranscriptional mechanism. Am J Physio Gastrointest Liver Physiol. 285: G282-290.
40. Van der Steen P, Husson SJ, Proost P, Van Damme J, Opdenakker G (2003) Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase. Biochem Biophys Res Commun 310: 889-896.
41. Heo J, Mondal TK, Gao D, Kasten-Jolly J, Kishikawa H, Lawrence DA (2006) Posttranscriptional Inhibition of Interferon-Gamma Production by Lead. Toxicological Sciences 96: 92-100.
42. Shanmugam N, Ransohoff RM, Natarajan R (2006) Interferon-y-inducible protein (IP)-10 mRNA stabilized by RNA-binding proteins in monocytes treated with S100b. Journal of Biological Chemistry 281: 31212-31221.
43. Hensbergen P, Verzijl D, Balog CI, Dijkman R, ven der Schors RC, van der Raaij-Helmer EM, van der Plas MJ, Leurs R, Deelder AM, Smit MJ, Tensen CP (2004) Furin is a chemokine-modifying enzyme: in vitro and in vivo processing of CXCL10 generates a C-terminally truncated chemokine retaining full activity. J Biol Chem 279: 13402-13411.
44. Campanella G, Grimm J, Manice LA, Colvin RA, Medoff BD, Wojtkiewicz GR, Weissleder R, Luster AD (2006) Oligomerization of CXCL10 is necessary for endothelial cell presentation and in vivo activity. J Immunol. 177: 6991-6998.
45. Tien M, Girardin SE, Regnault B, Le Bourhis L, Dillies MA, Coppée JY, Bourdet-Sicard R, Sansonetti PJ, Pédron T (2006) Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol. 176: 3841.
46. Lahat N, Rahat MA, Kinarty A, Weiss-Cerem L, Pinchevski S, Bittermann H (2008) Hypoxia enhances lysosomal TNF(alpha) degradation in mouse peritoneal makrophages. Am J Physiol Cell Physiol In press.
47. Isowa N, Keshavjee SH, Liu M (2000) Role of microtubules in LPS-induced macrophage inflammatory protein-2 production from rat pneumocytes. Am J Physiol Lung Cell Mol Physiol 279: L1075-1082.
48. Dardalhon V, Géminard C, Reggion H, Vidal M, Sainte-Marie J (2002) Fractionation analysis of the endosomal compartment during rat reticulocyte maturation. Cell Biol Int 26: 669-678.
49. Marinari U, Nitti M, Pronzato MA, Domenicotti C (2003) Role of PKC-dependent pathways in HNE-induced cell protein transport and secretion. Mol Aspects Med. 24: 205-211.
50. Schähs P, Weidinger P, Probst OC, Svoboda B, Stadlmann J, Heug H, Waerner T, Mach L (2008) Cellular repressor of E1A-stimulated genes is a bona fide lysosomal protein which undergoes proteolytic maturation during its biosynthesis. Exp Cell Res in press.
51. Chapman T, Plosker GL, Figgitt DP (2006) VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases. Drugs 66: 1371-1387.
52. Kim S, Tonkonogy SL, Albright CA, Tsang J, Balish EJ, Braun J, Huycke MM, Sartor RB (2005) Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128: 891-906.